NCT03858725View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

April 5, 2019

Study Completion Date

May 8, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

D569 Tab.

D569 Tab. 1T single oral administration under fasting condition

DRUG

CKD-374 5mg Tab.

CKD-374(Tofacitinib) 5mg Tab. 1T single oral administration under fasting condition

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY